HCV virological assessment

Journal of Hepatology

Volumn 44, Issue SUPPL. 1, 2006, Pages

  Forns, Xavier ^a   Costa, Josep ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Antibody assays; Assessment; Hepatitis C; HIV; Viral load

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOCOMPETENCE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPING; VIRUS LOAD; VIRUS TYPING;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 30144435324     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.010     Document Type: Conference Paper

References (31)

1. J.M. Pawlotsky Use and interpretation of virological tests for hepatitis C Hepatology 36 2002 S65 S73
2. J.M. Pawlotsky Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics Semin Liver Dis 23 2003 3 11
3. X. Forns, and J. Bukh Methods for determining the hepatitis C virus genotype Viral Hepat Rev 4 1998 1 19
4. X. Forns, and J. Bukh The molecular biology of hepatitis C virus. Genotypes and quasispecies Clin Liver Dis 3 1999 693 716
5. J. Bukh, R.H. Miller, and R.H. Purcell Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes Semin Liver Dis 15 1995 41 63
6. J. Bukh, R.H. Miller, and R.H. Purcell Genetic heterogeneity of the hepatitis C virus Princess Takamatsu Symp 25 1995 75 91
7. V. Bhattacherjee, L.E. Prescott, I. Pike, B. Rodgers, H. Bell, and A.R. El Zayadi Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6 J Gen Virol 76 1995 1737 1748
8. X. Forns, M.D. Maluenda, F.X. Lopez-Labrador, S. Ampurdanes, E. Olmedo, and J. Costa Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients J Clin Microbiol 34 1996 2516 2521
9. D. Klein Quantification using real-time PCR technology: applications and limitations Trends Mol Med 8 2002 257 260
10. J.M. Barbeau, J. Goforth, A.M. Caliendo, and F.S. Nolte Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent J Clin Microbiol 42 2004 3739 3746
11. J.J. Lefrere, F. Roudot-Thoraval, F. Lunel, S. Alain, M.L. Chaix, and E. Dussaix Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum J Clin Microbiol 42 2004 2027 2030
12. S. Laperche, N. Le Marrec, N. Simon, F. Bouchardeau, C. Defer, and M. Maniez-Montreuil A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection Transfusion 43 2003 958 962
13. P. Veillon, C. Payan, G. Picchio, M. Maniez-Montreuil, P. Guntz, and F. Lunel Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy J Clin Microbiol 41 2003 3212 3220
14. M. Buti, C. Mendez, M. Schaper, S. Sauleda, A. Valdes, and F. Rodriguez-Frias Hepatitis C virus core antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin J Hepatol 40 2004 527 532
15. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 2002 S21 S29
16. M.W. Fried, M. Shiffman, K.R. Reddy, C. Smith, G. Marinos, and F. Gonçales Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
17. S.J. Hadziyannis, H. Sette Jr, T.R. Morgan, V. Balan, M. Diago, and P. Marcellin Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 140 2004 346 355
18. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, and R. Reindollar Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
19. M. Shuhardt, and D.R. Gretch Hepatitis C and G viruses P. Murray E. Baron J. Jorgensen M. Pfaller R. Yolken Manual of clinical microbiology 2003 ASM Press Washington, DC 1480 1494
20. M.S. Sulkowski, and D.L. Thomas Hepatitis C in the HIV-infected patient Clin Liver Dis 7 2003 179 194
21. D.L. Thomas Hepatitis C and human immunodeficiency virus infection Hepatology 36 2002 S201 S209
22. M.S. Sulkowski, and D.L. Thomas Hepatitis C in the HIV-infected person Ann Intern Med 138 2003 197 207
23. C.L. Thio, K.R. Nolt, J. Astemborski, D. Vlahov, K.E. Nelson, and D.L. Thomas Screening for hepatitis C virus in human immunodeficiency virus-infected individuals J Clin Microbiol 38 2000 575 577
24. B.A. Piasecki, J.D. Lewis, K.R. Reddy, S.L. Bellamy, S.B. Porter, and R.M. Weinrieb Influence of alcohol use, race, and viral co-infections on spontaneous HCV clearance in a US veteran population Hepatology 40 2004 892 899
25. V. Soriano, M. Perez-Olmeda, P. Rios, M. Nunez, J. Garcia-Samaniego, and J. Gonzalez-Lahoz Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients AIDS Res Hum Retroviruses 20 2004 351 353
26. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-Garcia, and A. Lazzarin Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
27. T. Yoo, S. Donfield, A. Lail, H. Lynn, and E. Daar Hemophilia growth and development study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease J Infect Dis 191 2005 4 10
28. M. Leruez-Ville, Q.T. Nguyen, P. Cohen, S. Cocco, M. Nouyou, and F. Ferriere Large-scale analysis of hepatitis C virus serological typing assay: effectiveness and limits J Med Virol 55 1998 18 23
29. M. Bonacini, S. Govindarajan, L.M. Blatt, P. Schmid, A. Conrad, and K.L. Lindsay Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA J Viral Hepat 6 1999 203 208
30. M. Perez-Olmeda, M. Nunez, M. Romero, J. Gonzalez, A. Castro, and J.R. Arribas Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients AIDS 17 2003 1023 1028
31. F.J. Torriani, R.M. Ribeiro, T.L. Gilbert, U.M. Schrenk, M. Clauson, and D.M. Pacheco Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV co-infection J Infect Dis 188 2003 1498 1507